Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substitution therapy for heroin addiction.

James Bell1, Alain Dru, Benedikt Fischer

  • 1The Langton Centre, Sydney, NSW, Australia. jamesb@sesahs.nsw.gov.au

Substance Use & Misuse
|August 16, 2002
PubMed
Summary

Substitution treatment for heroin addiction, using opioid agonist drugs, is growing. Key challenges include balancing access with diversion control, integrating primary care, and overcoming stigma, which impacts policy stability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and development of a novel media-separated valve for flow-controlled expiration during mechanical ventilation.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2026
Same author

Correlates of Engagement and Associations with Outcomes in a Cannabis Harm Reduction Mobile App for Youth with First-Episode Psychosis: Exploratory Findings from the CHAMPS Pilot Randomized Controlled Trial.

JMIR formative research·2026
Same author

Online promotional practices and apparent violations from licensed cannabis retail stores in Canada.

The International journal on drug policy·2026
Same author

Cannabis Legalization Outcomes in Canada: Trading Off Increased Health Problem for Reduced Crime Burdens Is Not Good Enough.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

Recent decreases in drug overdose deaths: Assessing evidence for supply-related drivers and implications for health-oriented drug policy in Canada.

Preventive medicine·2026
Same author

Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada's federal correctional system.

Canadian journal of public health = Revue canadienne de sante publique·2026

Area of Science:

  • Addiction Medicine
  • Public Health Policy
  • Pharmacology

Background:

  • Substitution treatment for heroin addiction has seen increased utilization over the past decade.
  • This treatment involves the maintenance prescribing of opioid agonist drugs for opioid-dependent individuals.
  • The review examines the recent history and critical issues surrounding this treatment modality in five countries.

Purpose of the Study:

  • To review the recent history of substitution treatment in Canada, the U.K., Australia, Israel, and France.
  • To identify and analyze the critical issues common to substitution treatment across these nations.
  • To explore the challenges related to accessibility, diversion, primary care integration, and stigma.

Main Methods:

  • A review of the recent history of substitution treatment in five selected countries.

Related Experiment Videos

  • Analysis of critical issues concerning accessibility, diversion, and primary care involvement.
  • Examination of the impact of stigma on treatment policy and community support.

    • Main Results:

    • Common critical issues identified across all five countries include balancing treatment accessibility with diversion prevention.
    • There is a trend towards increased primary health care involvement in delivering opioid agonist maintenance treatment (OMT), though with some ambivalence.
    • Stigma associated with addiction and OMT significantly strains the treatment system and makes it vulnerable to policy changes.

    Conclusions:

    • Substitution treatment faces similar challenges globally, particularly concerning access, diversion, and the role of primary care.
    • Overcoming stigma is crucial for the sustainability and effectiveness of opioid agonist maintenance treatment.
    • Policy stability for substitution treatment is threatened by societal values and political shifts.